There have been numerous reports, medical studies, and clinical data to support the use of hyperbaric oxygen therapy (HBOT) for a vast number of liver diseases; namely, acute liver injury, nonalcoholic steatohepatitis, liver transplantation, fibrosis and cancer, especially for hepatic artery thrombosis. Review of the current literature tell us that HBOT can have a powerful effect on promoting liver regeneration. In terms of liver diseases, it seems that the key physiological benefits of HBOT are in its antioxidant and anti-inflammatory role, helping to provide protection for damaged liver tissue. The combination of extra protection (though antioxidant and anti-inflammatory support) and enhanced regeneration, make HBOT a potential valuable tool for many liver diseases.The authors of this study take a more in-depth analysis of HBOT’s role within these disease while also citing relevant studies <view study>